Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Conditions
Interventions
Placebo
Vilazodone
+1 more
Locations
52
United States
Forest Investigative Site 073
Imperial, California, United States
Forest Investigative Site 052
Los Angeles, California, United States
Forest Investigative Site 023
Murrieta, California, United States
Forest Investigative Site 004
Orange, California, United States
Forest Investigative Site 037
San Diego, California, United States
Forest Investigative Site 006
Washington D.C., District of Columbia, United States
Start Date
July 11, 2013
Primary Completion Date
March 17, 2016
Completion Date
October 5, 2016
Last Updated
December 24, 2019
NCT07226661
NCT07115329
NCT06793397
NCT07025720
NCT06804525
NCT06780917
Lead Sponsor
Forest Laboratories
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions